Design and validation of an e-textile-based wearable system for remote health monitoring

The paper presents a new e-textile-based system, named SWEET Shirt, for the remote monitoring of biomedical signals. The system includes a textile sensing shirt, an electronic unit for data transmission, a custom-made Android application for real-time signal visualisation and a software desktop for advanced digital signal processing. The device allows for the acquisition of electrocardiographic, bicep electromyographic and trunk acceleration signals. The sensors, electrodes, and bus structures are all integrated within the textile garment, without any discomfort for users. A wide-ranging set of algorithms for signal processing were also developed for use within the system, allowing clinicians to rapidly obtain a complete and schematic overview of a patient's clinical status. The aim of this work was to present the design and development of the device and to provide a validation analysis of the electrocardiographic measurement and digital processing. The results demonstrate that the information contained in the signals recorded by the novel system is comparable to that obtained via a standard medical device commonly used in clinical environments. Similarly encouraging results were obtained in the comparison of the variables derived from the signal processing.</p

Association between PaO2/FiO2 ratio and thrombotic events in COVID-19 patients

PaO2/FiO(2) (P/F ratio) is considered a marker of hypoxia/hypoxemia and mortality. Several prothrombotic changes are associated with the decrease of P/F ratio. The role of P/F ratio in patients with arterial and venous thrombosis remains unclear. The aim of this study was to assess in patients with coronavirus disease 2019 (COVID-19), the association between P/F ratio and arterial/venous thrombosis. One thousand and four hundred and six COVID-19 patients were recruited; 289 (21%) patients had P/F ratio &lt; 200 and 1117 (79%) &gt;= 200. Compared to the patients with P/F ratio &gt;= 200, those with P/F ratio &lt; 200 were older and with higher levels of glycemia, D-dimer and lower levels of albumin. Multiple linear regression analysis showed that albumin (standardized coefficient beta: 0.156; SE: 0.001; p = 0.0001) and D-dimer (standardized coefficient beta: -0.135; SE: 0.0001; p = 0.0001) were associated with P/F ratio. During the hospitalization 159 patients were transferred in intensive care unit (ICU), 253 patients died, 156 patients had arterial or venous thrombotic events. A bivariate logistic analysis was performed to analyze the predictors of thrombosis in COVID-19 patients; P/F ratio &lt; 200 (Odds Ratio: [OR] 1.718, 95% Confidence Interval [CI] 1.085-2.718, p = 0.021), albumin (OR 1.693, 95% CI 1.055-2.716, p = 0.029), D-dimer (OR 3.469, 95% CI 2.110-5.703, p &lt; 0.0001), coronary artery disease (CAD) (OR 1.800, 95% CI 1.086-2.984, p = 0.023) and heart failure (OR 2.410 95% CI 1.385-4.193, p = 0.002) independently predicted thrombotic events in this population. This study suggests that the P/F ratio is associated with thrombotic events by promoting a hypercoagulation state in patients hospitalized for COVID-19

An explainable model of host genetic interactions linked to COVID-19 severity

We employed a multifaceted computational strategy to identify the genetic factors contributing to increased risk of severe COVID-19 infection from a Whole Exome Sequencing (WES) dataset of a cohort of 2000 Italian patients. We coupled a stratified k-fold screening, to rank variants more associated with severity, with the training of multiple supervised classifiers, to predict severity based on screened features. Feature importance analysis from tree-based models allowed us to identify 16 variants with the highest support which, together with age and gender covariates, were found to be most predictive of COVID-19 severity. When tested on a follow-up cohort, our ensemble of models predicted severity with high accuracy (ACC = 81.88%; AUCROC = 96%; MCC = 61.55%). Our model recapitulated a vast literature of emerging molecular mechanisms and genetic factors linked to COVID-19 response and extends previous landmark Genome-Wide Association Studies (GWAS). It revealed a network of interplaying genetic signatures converging on established immune system and inflammatory processes linked to viral infection response. It also identified additional processes cross-talking with immune pathways, such as GPCR signaling, which might offer additional opportunities for therapeutic intervention and patient stratification. Publicly available PheWAS datasets revealed that several variants were significantly associated with phenotypic traits such as "Respiratory or thoracic disease", supporting their link with COVID-19 severity outcome.A multifaceted computational strategy identifies 16 genetic variants contributing to increased risk of severe COVID-19 infection from a Whole Exome Sequencing dataset of a cohort of Italian patients

The polymorphism L412F in TLR3 inhibits autophagy and is a marker of severe COVID-19 in males

The polymorphism L412F in TLR3 has been associated with several infectious diseases. However, the mechanism underlying this association is still unexplored. Here, we show that the L412F polymorphism in TLR3 is a marker of severity in COVID-19. This association increases in the sub-cohort of males. Impaired macroautophagy/autophagy and reduced TNF/TNFα production was demonstrated in HEK293 cells transfected with TLR3L412F-encoding plasmid and stimulated with specific agonist poly(I:C). A statistically significant reduced survival at 28 days was shown in L412F COVID-19 patients treated with the autophagy-inhibitor hydroxychloroquine (p = 0.038). An increased frequency of autoimmune disorders such as co-morbidity was found in L412F COVID-19 males with specific class II HLA haplotypes prone to autoantigen presentation. Our analyses indicate that L412F polymorphism makes males at risk of severe COVID-19 and provides a rationale for reinterpreting clinical trials considering autophagy pathways. Abbreviations: AP: autophagosome; AUC: area under the curve; BafA1: bafilomycin A1; COVID-19: coronavirus disease-2019; HCQ: hydroxychloroquine; RAP: rapamycin; ROC: receiver operating characteristic; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; TLR: toll like receptor; TNF/TNF-α: tumor necrosis factor

SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues

Variability in SARS-CoV-2 susceptibility and COVID-19 disease severity between individuals is partly due to genetic factors. Here, we identify 4 genomic loci with suggestive associations for SARS-CoV-2 susceptibility and 19 for COVID-19 disease severity. Four of these 23 loci likely have an ethnicity-specific component. Genome-wide association study (GWAS) signals in 11 loci colocalize with expression quantitative trait loci (eQTLs) associated with the expression of 20 genes in 62 tissues/cell types (range: 1:43 tissues/gene), including lung, brain, heart, muscle, and skin as well as the digestive system and immune system. We perform genetic fine mapping to compute 99% credible SNP sets, which identify 10 GWAS loci that have eight or fewer SNPs in the credible set, including three loci with one single likely causal SNP. Our study suggests that the diverse symptoms and disease severity of COVID-19 observed between individuals is associated with variants across the genome, affecting gene expression levels in a wide variety of tissue types

A first update on mapping the human genetic architecture of COVID-19

peer reviewe

The E-Textile for Biomedical Applications: A Systematic Review of Literature

The use of e-textile technologies spread out in the scientific research with several applications in both medical and nonmedical world. In particular, wearable technologies and miniature electronics devices were implemented and tested for medical research purposes. In this paper, a systematic review regarding the use of e-textile for clinical applications was conducted: the Scopus and Pubmed databases were investigate by considering research studies from 2010 to 2020. Overall, 262 papers were found, and 71 of them were included in the systematic review. Of the included studies, 63.4% focused on information and communication technology studies, while the other 36.6% focused on industrial bioengineering applications. Overall, 56.3% of the research was published as an article, while the remainder were conference papers. Papers included in the review were grouped by main aim into cardiological, muscular, physical medicine and orthopaedic, respiratory, and miscellaneous applications. The systematic review showed that there are several types of applications regarding e-textile in medicine and several devices were implemented as well; nevertheless, there is still a lack of validation studies on larger cohorts of subjects since the majority of the research only focuses on developing and testing the new device without considering a further extended validation

Benchmarking between two wearable inertial systems for gait analysis based on a different sensor placement using several statistical approaches

Despite the growing use of different wearable inertial systems for gait analysis in clinical setting, also based on a different sensor placement, there is still a lack of knowledge about the agreement between them and their repeatability. The purpose of this study is to investigate the agreement between two commercial wearable inertial systems for gait analysis: Opal and G-Walk Systems, and their repeatability. Fifty-three subjects, healthy and pathological, underwent a gait analysis session instrumented by both systems, seven spatiotemporal parameters were recorded. The study of agreement was carried out through Bland-Altman Analysis, Passing-Bablok regression and Paired t-test, the study of repeatability through the intra class correlation coefficient ICC(3,1). Study results showed a not perfect agreement between the two systems although they both showed good repeatability. This work underlines the importance to perform a study of agreement before using devices interchangeably or even as a replacement in order to have reliable measurements

Repeatability of Spatio-Temporal Gait Measurements in Parkinson’s Disease

Parkinson's Disease is one of the most common neurodegenerative disorders. Its principal symptoms regard motor area, and gait is one of the most affected motor characteristics. In clinical environment Parkinsonian gait is often assessed through gait analysis. Opal System by APDM is a commercial device used to perform gait analysis with inertial measurements units (IMUs). In this study we evaluate repeatability of spatio-temporal gait measurements, assessed with Opal Instrumented Stand and Walk (ISAW) test on a cohort of forty-five Parkinsonian patients. Repeatability is assessed by means of Intraclass Correlation Coefficient (ICC) and Repeatability Limit (RL) for each variable. RL is then compared to the absolute value of difference (DoM) of PD patients' measurements mean and normative mean of the same variable, in order to understand which variable can better characterize Parkinsonian gait with respect to normal gait. Results show that gait and turn measurements are more repeatable than sway and anticipatory postural adjustments variables, and they are proper indexes to better identify Parkinsonian walking features